Healthline
October 6, 2025
Share on PinterestA new trial shows that a common nasal spray may help lower the risk of contracting COVID-19 and other respiratory illnesses. Professional Studio Images/Getty […]
October 5, 2025
Share on PinterestA new report on the mental health side effects of finasteride provides some evidence to support further research. Stan Pritchard/Alamy A new report raises […]
October 3, 2025
Share on PinterestThe Food and Drug Administration (FDA) has been investigating the Listeria outbreak in ready-made pasta meals since June. Design by Healthline; Photography courtesy of […]
October 2, 2025
Share on PinterestFor some females experiencing menopause weight gain, dietary changes may not be enough on their own. Getty Images/Cultura Creative More women are seeking solutions […]
Medscape
July 1, 2025
TOPLINE: Prescribing stimulants for teens and adults with attention-deficit/hyperactivity disorder (ADHD) via telehealth was not associated with increased risk for substance use disorder (SUD) compared with […]
July 1, 2025
Autoimmune diseases, especially in women, are associated with nearly a two-fold increased risk for affective disorders, new research showed. An analysis of 1.5 million adults showed […]
July 1, 2025
At the recent 44th Health Economics Association Conference in Madrid, Spain, researchers presented compelling evidence that traumatic experiences in childhood have long-lasting effects on both health […]
July 1, 2025
(This story has been refiled to change the picture) (Reuters) -U.S. President Donald Trump’s administration cancelled a major contract to supply emergency kits for rape survivors […]
FDA
December 8, 2025
[December 8, 2025] The U.S. Food and Drug Administration today approved the first generic version of Imvexxy® (estradiol vaginal inserts). This approval will provide women additional […]
December 8, 2025
[12/8/2025] The U.S. Food and Drug Administration (FDA) has qualified the first AI drug development tool, the AI-Based Histologic Measurement of NASH (AIM-NASH), to help pathologists […]
December 8, 2025
As outlined in the GDUFA III Commitment Letter, these performance metrics must be reported each fiscal year. Original and PAS Review GDUFA FY Performance Review Time […]
December 5, 2025
Reports Mandated by FDORA The Food and Drug Omnibus Reform Act of 2022 (FDORA) requires FDA to develop several different kinds of informational documents, including public […]
